U.S. Genetic Testing Market Size, Share, Trends & COVID-19 Impact Analysis, By Technique (PCR, DNA Sequencing, Microarrays, and Others), By Application (Cardiology, Oncology, Pharmacogenomics, Cognitive Dysfunction, Pathogenomics, and Others), By Payer (Public Health Insurance, Private Health Insurance, and Out-of-Pocket), By End-User (Hospitals, and Independent Laboratories) & Forecast, 2020-2027

Last Updated: November 17, 2025 | Format: PDF | Report ID: FBI105034

To get information on various segments, share your queries with us

ATTRIBUTE	DETAILS
Study Period	2016-2027
Base Year	2019
Forecast Period	2020-2027
Historical Period	2016-2018
Unit	Value (USD Billion)
Segmentation	Technique, Application, Payer, and End User
By Technique	PCR DNA Sequencing Microarrays Others
By Application	Cardiology Oncology Pharmacogenomics Cognitive Dysfunction Pathogenomics Others
By Payer	Public Health Insurance Private Health Insurance Out-of-Pocket
By End-User	Hospitals Independent Laboratories